These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22935448)

  • 41. On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus.
    Wang Z; Huang JD; Wong KL; Wang PG; Zhang HJ; Tanner JA; Spiga O; Bernini A; Zheng BJ; Niccolai N
    FEBS J; 2011 Jan; 278(2):383-9. PubMed ID: 21134131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase.
    Jang KJ; Lee NR; Yeo WS; Jeong YJ; Kim DE
    Biochem Biophys Res Commun; 2008 Feb; 366(3):738-44. PubMed ID: 18082623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
    Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM
    Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
    Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
    Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS coronavirus anti-infectives.
    Tong TR
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):297-308. PubMed ID: 18221155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards the design of flavivirus helicase/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain.
    Xu T; Sampath A; Chao A; Wen D; Nanao M; Luo D; Chene P; Vasudevan SG; Lescar J
    Novartis Found Symp; 2006; 277():87-97; discussion 97-101, 251-3. PubMed ID: 17319156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generalized open-source workflows for atomistic molecular dynamics simulations of viral helicases.
    Raubenolt B; Blankenberg D
    Gigascience; 2024 Jan; 13():. PubMed ID: 38869150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
    Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
    Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
    Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
    Borowski P; Lang M; Haag A; Baier A
    Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase.
    Shum KT; Tanner JA
    Chembiochem; 2008 Dec; 9(18):3037-45. PubMed ID: 19031435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
    Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
    SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
    Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Z-RNA and the Flipside of the SARS Nsp13 Helicase: Is There a Role for Flipons in Coronavirus-Induced Pathology?
    Herbert A; Poptsova M
    Front Immunol; 2022; 13():912717. PubMed ID: 35784331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay.
    Aouadi W; Eydoux C; Coutard B; Martin B; Debart F; Vasseur JJ; Contreras JM; Morice C; Quérat G; Jung ML; Canard B; Guillemot JC; Decroly E
    Antiviral Res; 2017 Aug; 144():330-339. PubMed ID: 28676301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.